FIELD: organic chemistry, biochemistry, pharmacy.
SUBSTANCE: invention relates to nucleoside analogues of the formula (1) wherein R1 represents hydrogen atom (H) or hydroxyl-protected group; R2 represents hydrogen atom (H), hydroxyl-protective group, phosphoric acid group, phosphoric acid-protected group or group of the formula P(R3)R4 wherein R and R4 are similar or different and represent hydroxyl group, hydroxyl-protected, alkoxy-group, alkylthio-group, cyanoalkoxy-group, amino-group substituted with alkyl group; A represents alkylene group comprising from 1 to 4 carbon atoms; B represents substituted purine-9-yl group or substituted 2-oxopyrimidine-1-yl group comprising at least one substituent taken among hydroxyl group, hydroxyl-protected group, amino-group, amino-protected group, alkyl group. Also, invention relates to oligonucleotide analogues comprising one or more structures of the formula (2) wherein A and B have values indicated for the formula (1). Oligonucleotide analogues or their pharmacologically acceptable salts can be used as medicinal preparations eliciting nonsense-activity or antigenic activity.
EFFECT: valuable medicinal properties of compounds.
12 cl, 6 tbl, 48 ex
Title | Year | Author | Number |
---|---|---|---|
PHOSPHORAMIDITE DERIVATIVE AND METHOD OF PRODUCING RNA OLIGO | 2005 |
|
RU2415862C2 |
DERIVATIVES OF AMINOALCOHOLS, PHARMACEUTICAL COMPOSITION, METHOD FOR PROPHYLAXIS OR TREATMENT, INTERMEDIATE COMPOUNDS AND METHOD FOR PREPARING INTERMEDIATE COMPOUNDS | 2001 |
|
RU2233839C1 |
C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
NOVEL ANALOGUES OF 2',5'-OLIGOADENYLATE OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND THEIR USING | 2003 |
|
RU2311422C2 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
BENZIMIDAZOLE DERIVATIVE, HUMAN CHYMASE INHIBITOR, THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2263674C2 |
NUCLEOSIDE DERIVATIVES OF 1,3-DIAZA-2-OXOPHENOXAZINE AS HERPESVIRUS REPLICATION INHIBITORS | 2019 |
|
RU2731381C1 |
DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS | 2001 |
|
RU2267490C2 |
ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF | 2001 |
|
RU2268259C2 |
CYCLOALKYL-SUBSTITUTED DERIVATIVES OF AMINOMETHYLPYRROLIDINE AND ANTIBACTERIAL AGENT BASED ON THEREOF | 1999 |
|
RU2248970C2 |
Authors
Dates
2004-08-10—Published
2000-02-10—Filed